CONTRIBUTION AND EXCHANGE AGREEMENTContribution and Exchange Agreement • June 8th, 2023 • Lewis & Clark Ventures I, LP • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJune 8th, 2023 Company Industry Jurisdiction
SW PARENTCO, INC. SECURED CONVERTIBLE NOTE PURCHASE AGREEMENTSecured Convertible Note Purchase Agreement • June 8th, 2023 • Lewis & Clark Ventures I, LP • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJune 8th, 2023 Company Industry JurisdictionThis Secured Convertible Note Purchase Agreement, dated as of May 29, 2023 (this “Agreement”), is entered into by and among SW ParentCo, Inc., a Delaware corporation (the “Company”), and the undersigned persons and entities (each an “Investor” and, collectively, the “Investors”).
AGREEMENT AND PLAN OF MERGER by and among SW PARENTCO, INC. SW MERGERCO, INC. and GreenLight Biosciences Holdings, PBC Dated as of May 29, 2023Merger Agreement • June 8th, 2023 • Lewis & Clark Ventures I, LP • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJune 8th, 2023 Company Industry JurisdictionThis Agreement and Plan of Merger (the “Agreement”), dated as of May 29, 2023, is by and among SW ParentCo, Inc., a Delaware corporation (“Parent”), SW MergerCo, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), and GreenLight Biosciences Holdings, PBC, a Delaware public benefit corporation (the “Company”).
Joint Filing AgreementJoint Filing Agreement • June 8th, 2023 • Lewis & Clark Ventures I, LP • Biological products, (no disgnostic substances)
Contract Type FiledJune 8th, 2023 Company IndustryIn accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13D referred to below) on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the Common Stock, par value $0.0001 per share, of GreenLight Biosciences Holdings, PBC, and that this Agreement may be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.